ProfileGDS4132 / 214130_s_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 42% 47% 53% 41% 40% 30% 33% 41% 50% 51% 32% 64% 54% 43% 45% 33% 29% 43% 44% 35% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101108.75642
GSM201543Muscle PCOS pioglitazone 121117.84747
GSM201544Muscle PCOS pioglitazone 161146.33853
GSM201545Muscle PCOS pioglitazone 201114.93641
GSM201829Muscle PCOS pioglitazone 231110.2140
GSM201830Muscle PCOS pioglitazon 25176.092130
GSM201831Muscle PCOS pioglitazone 27179.452533
GSM201832Muscle PCOS pioglitazone 31105.87541
GSM201833Muscle PCOS pioglitazone 41124.62550
GSM201834Muscle PCOS pioglitazone 81133.16351
GSM201835Muscle PCOS after pioglitazone 10265.515532
GSM201836Muscle PCOS after pioglitazone 122175.96264
GSM201837Muscle PCOS after pioglitazone 162128.00854
GSM201838Muscle PCOS after pioglitazone 202100.33943
GSM201839Muscle PCOS after pioglitazone 232111.74345
GSM201840Muscle PCOS after pioglitazone 25278.691733
GSM201841Muscle PCOS after pioglitazone 27255.910729
GSM201842Muscle PCOS after pioglitazone 3293.050243
GSM201843Muscle PCOS after pioglitazone 42110.54944
GSM201844Muscle PCOS after pioglitazone 8282.20335